Effect of Bromocriptine Mesylate as Add-On Therapy in Obese Type 2 Diabetes Mellitus Patients
نویسندگان
1 M.D. (Medicine) P.G. Student Department of Medicine, Netaji Shubash Chandra Bosh ,Government Medical College, Jabalpur, Madhya. Pradesh , India
2 MBBS, M.D. (PSM) Associate Professor, Department of Community Medicine. Dr. Panjabrao Deshmukh .Medical College, Amravati Maharashtra ,India
3 PG Student (MD Medicine) Department of Medicine. Dr. Panjabrao Deshmukh .Medical College, Amravati Maharashtra ,India
4 MBBS, M.D. (Medicine) Associate Professor, Department of Medicine. Dr. Panjabrao Deshmukh Medical College, Amravati Maharashtra , INDIA
doi
چکیده
Six months administration of bromocriptine mesylate significantly decreased glycated hemoglobin (HbA1c), fasting blood sugar, postprandial blood sugar, and weight of 22 Indian obese patients with type 2 diabetes mellitus with no serious adverse events. Therefore, the novel mechanism of action, efficacy and acceptable safety profile makes this drug an attractive option ...
